Similar to transaminases, in NASH-non-HCC, IL-6 levels, as a marker of hepatic inflammatory response, were higher in noncirrhotic patients and further increased in NHc (see Figure S1A, Supplementary Digital Content 1, http://links.lww.com/CTG/A212). Here, IL6 is linked to hepatocellular carcinoma.